Experimental autoimmune myasthenia gravis induction in B cell-deficient mice
スポンサーリンク
概要
著者
-
Wahren Britta
Department Of Virology Swedish Institute For Infectious Disease Control
-
Link H
Experimental Neurology Unit Division Of Neurology Karolinska Institutet Huddinge University Hospital
-
LI Hulun
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
SHI Fu-dong
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
HE Bing
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
BAKHEIT Moiz
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
WAHREN Britta
Swedish Institute for Infectious Disease Control, Huddinge University Hospital
-
BERALOF Anna
Department of Immunology, Microbiology, Pathology and Infectious Diseases, Division of Clinical Bact
-
SANDSTEDT Karin
Department of Immunology, Microbiology, Pathology and Infectious Diseases, Division of Clinical Bact
-
LINK Hans
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
Link Hans
Division Of Neuroimmunology Neurotec Karolinska Institute
-
Shi Fu-dong
Microbiology And Tumor Biology Center (mtc) Karolinska Institutet
-
Wahren Britta
Swedish Institute For Infectious Disease Control Microbiology And Tumor Biology Center Karolinska In
-
He Bing
Division Of Neurology Karolinska Institute Huddinge University Hospital
-
Bakheit Moiz
Division Of Neurology Karolinska Institute Huddinge University Hospital
-
Beralof Anna
Department Of Immunology Microbiology Pathology And Infectious Diseases Division Of Clinical Bacteri
-
Sandstedt Karin
Department Of Immunology Microbiology Pathology And Infectious Diseases Division Of Clinical Bacteri
関連論文
- Experimental autoimmune myasthenia gravis induction in B cell-deficient mice
- Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99
- Therapeutic potential of IFN-γ-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis
- Human Immunodeficiency Virus-Type 1 Specific Cellular Immunity in Chronic Infected Patients on Prolonged Highly Active Antiretroviral Treatment and on Structured Treatment Interruption
- Tumor necrosis factor receptor-1 is critically involved in the development of experimenetal autoimmune myasthenia gravis
- Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing gransforming growth factor-β-secreting cells and suppressing chemokine expression